AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Ilya Sutskever rejected Meta’s bid for his $32B startup, so Zuckerberg is hiring his CEO instead
2
Microsoft gives Israeli employees time off, while Mobileye and others rush to aid displaced workers
3
Vibe coding fever: Solo entrepreneur’s Base44 acquired by Wix for $80 million
4
Weizmann Institute suffers over $500 million in damage from missile strike
5
Combat-ready and camera-eyed: The X-Intra drone joins Israel’s arsenal
More news

Cukierman

3 stories about Cukierman
Dr Laurent Choppe Managing Partner at Cukierman Co Life Sciences

Prepare for a year of M&As in Israeli life sciences companies

28.11.21|Laurent Choppe
Massive fund raising, significant growth in M&A deals and even a first Israeli biomed SPAC; Dr. Laurent Choppe, Managing Partner at Cukierman & Co. Life Sciences, explains the current trends behind the sector's amazing year and discusses what’s next
Dr Laurent Choppe Managing Partner at Cukierman Co Life Sciences

Israel third only to U.S. and China in Covid-19 solutions, says life sciences expert

17.07.20|Allon Sinai
"We don't talk anymore about devices or drugs. We talk about healthtech convergence, which for me is the future," explains Dr. Laurent Choppe, Managing Partner at Cukierman & Co. Life Sciences
אדוארד קוקירמן קטליסט

U.S.-China Trade War an Opportunity for Israeli Tech, Says Venture Capitalist

31.10.19|Lilach Baumer
Edouard Cukierman of Cukierman & Co. and Catalyst sees potential in the mounting trade tensions between the U.S. and China, and thinks Israeli companies should steer clear of Chinese politics